Please find below instructions to read before opening the submission page.
The final deadline to submit the abstract(s) is December 3, 2018. Abstracts will not be able to be submitted online after this date. The submitting author will receive notification of acceptance in January 2019. At the time of the confirmation of acceptance of your abstract, presenters will be requested to register for the congress.
|December 3, 2018||Abstract Submission Deadline|
|January 2019||Communication to authors on approved / rejected abstracts|
During the submission process, you will be asked to select the topic for your abstract. The topic is the general heading under which the abstract will be reviewed and later published in the congress materials, if accepted. The topic which best describes the subject of the abstract should be chosen. TTS reserves the right to reassign the topic for the abstract for the purposes of programming. (list of topics available at the bottom of this page)
All abstracts should be formatted into the following four sections:
All abstracts must be submitted electronically through the Congress abstract submission website
Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.
TTS regards plagiarism as serious professional misconduct. All abstracts are screened for plagiarism and when identified, the abstract and any other abstracts submitted by the same author are rejected.
To be eligible to submit an abstract, you must disclose that the authors/ scientists have not violated any aspect of The Transplantation Society Ethics statements (see details below) and that this research conforms with the ethical statements noted.
Scientific studies and clinical activities should be performed in keeping with the ethical principles delineated in the following policy documents:
The Meeting Scientific Advisory Committee may enquire further information on the ethical aspects when evaluating the abstracts.
Format of Presentation
You may opt to submit your abstract to be considered for an oral presentation, a poster presentation, or either (at the committee’s discretion).
Notification of Acceptance or Rejection to Corresponding Author
Notification of acceptance or rejection will be sent to the submitting (corresponding) author by January, 2019. Please note that only the corresponding author will receive the communication concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.
Rule of Two
Each presenting author may present a maximum of two abstracts during the entire meeting (oral, mini-orals or posters). The number of submissions is however not limited. Should an author have more than two abstracts accepted for presentation, a co-author must be named as presenter for one or more abstracts.
Intensive care and identification of donors
Establishment of brain death
Family approach and family care
Organ recovery and preservation
Organization of organ donation and allocation agencies
Histocompatibility testing models
Optimizing deceased donor organ utilization
Organ allocation: the right organ for the right recipient
Deceased donor infectious disease transmission
Presumed consent: opt-in vs opt-out countries
Public knowledge and attitude toward organ donation
Achieving self-sufficiency in deceased donation for prevention of organ trade and transplant tourism